Skip to ContentSkip to Navigation
Over ons Praktische zaken Waar vindt u ons J.K.E. Veraart

Publicaties

Demographic and clinical predictors of response and remission in the treatment of major depressive disorder with ketamine and esketamine: A systematic review

Oral esketamine in patients with treatment-resistant depression: a double-blind, randomized, placebo-controlled trial with open-label extension

Correction to: Psychedelics for the treatment of depression, anxiety, and existential distress in patients with a terminal illness: a systematic review

Phenomenology and therapeutic potential of patient experiences during oral esketamine treatment for treatment-resistant depression: an interpretative phenomenological study

Repeated oral esketamine in patients with treatment resistant depression and comorbid posttraumatic stress disorder

Holding on or letting go? Patient experiences of control, context, and care in oral esketamine treatment for treatment-resistant depression: A qualitative study

Maintenance ketamine treatment for depression: a systematic review of efficacy, safety, and tolerability

Psilocybine versus escitalopram bij depressieve stoornis

Psychedelics for the treatment of depression, anxiety, and existential distress in patients with a terminal illness: a systematic review

Repeated, low-dose oral esketamine in patients with treatment-resistant depression: pilot study

Pers/media

Ketamine tegen je depressie

Spectaculaire resultaten met ketamine als middel tegen depressie

Zeggen alle psychiaters ja tegen psychedelica?

Kamerleden verrast door positieve resultaten hallucinerende middelen als medicijn

UMCG’ers pleiten in de Tweede Kamer voor centrale regie psychedelische therapie voor kwetsbare patiënten